CAMPHOR is anticancerous properties 714-X claimed by supporters to have anticancer activity is camphor that has been chemically modified by the addition of an extra nitrogen atom. Chemical analysis of 714-X by the U.S. Food and Drug Administration found that it consists of 94 percent water; about 5 percent nitrate; 1.4 percent ammonium; less than 1 percent each ethanol, sodium, and chloride; and less than .01 percent camphor. 714-X is used as a complementary/alternative method in Canada, Western Europe, and Mexico to treat cancer, AIDS, and other diseases. It is not legally available in the United States.
DISTRIBUTOR Camphor is a white crystalline substance, obtained from the tree Cinnamonum camphora, but the name has been given to various concrete odorous volatile products, found in different aromatic plants. The commercial Camphor comes only from C. camphora and Dryobalanops camphora (fam. Dipterocarpacaea). The first gives our official Camphor, the latter the Borneo Camphor, which is much valued in the East, but unknown in Europe and America. C. camphora is an evergreen tree looking not unlike our linden; it grows to a great size, is manybranched, flowers white, small and clustered, fruit a red berry much like cinnamon.READ MORE
How is it promoted for use?
According to its proponents of 714-X, people with serious illnesses, such as cancer, carry tiny living particles in their bloodstream called somatids. Proponents claim that disease can be diagnosed and monitored by noting the number and forms of somatids in a person's blood. 714-X is said to cure cancer and AIDS by interfering with the flow of somatids through the bloodstream. This interference is said to cause the immune system to grow stronger and cause diseases to regress.
Proponents claim that cancer cells produce a substance called co-cancerogenic K factor (CKF), which protects the cells from the immune system. 714-X supposedly supplies the body with nitrogen, which strips this protective substance and leaves tumor cells vulnerable to attack by the immune system.
Evidence to support these claims has not been published in any available peer-reviewed, scientific journals.
What does it involve?
714-X is prepared as a sterile solution and injected into a lymph node in the groin. Ice packs are used to cool the area of injection both before and after. A course of treatment involves daily injections for 21 days, followed by 2 or 3 days of rest. The cycle typically repeated several times.
714-X can also be given nasally, using a nebulizer. This route is more commonly used for lung or oral cancers.
In Canada, 714-X is available only on a compassionate use basis. While it is not approved for general therapeutic use, doctors may request it under the Emergency Drug Release Program of Health Canada. It is not approved, however, for general therapeutic use. In October 2004, Health Canada instructed Naessen's company CERBE, the company that sells 714-X, to remove statements concerning 714-X from its public Web site.
The Food and Drug Administration (FDA) has not approved 714-X for use in the United States, and it is illegal to import it into the country.
What is the history behind it?
Early in his career, French-born scientist Gaston Naessens developed the somatoscope, a special microscope that he used to examine blood at extremely high magnifications. Using the somatoscope, Naessens claimed to have discovered tiny living organisms called somatids in the blood of people with serious diseases, including cancer. He believed that somatids were different from bacteria, fungi, viruses, or other microbes previously identified by other scientists and that they were responsible for the development of disease.
References
714-X (PDQ®). National Cancer Institute. Accessed at: www.cancer.gov/cancertopics/pdq/cam/714-X/healthprofessional on June 11, 2008.
714-X information package. 1996. Canadian Breast Cancer Research Alliance. Accessed at: www.breast.cancer.ca/media_news_resource_centre/resources/literature_reviews/714-X/ on June 21, 2007. Site discontinued.
Barrett S. Fanciful claims for 714X. 2002. Accessed at: www.quackwatch.org/01QuackeryRelatedTopics/Cancer/714x.html on June 11, 2008.
Ernst E, Cassileth BR. How useful are unconventional cancer treatments? Eur J Cancer. 1999;35:1608-1613.
Kaegi E. Unconventional therapies for cancer: 6. 714-X. Task Force on Alternative Therapeutic of the Canadian Breast Cancer Research Initiative. CMAJ. 1998;158:1621-1624.
Kurtzweil P. Investigators reports: promoter of 714X Cure-All Faces Prison for Selling Unapproved Drug. FDA Consumer 1996. Online at: www.fda.gov/fdac/departs/996_irs.html. Accessed June 21, 2007.
Note: This information may not cover all possible claims, uses, actions, precautions, side effects or interactions. It is not intended as medical advice, and should not be relied upon as a substitute for consultation with your doctor, who is familiar with your medical situation.
LINKLINK
LINK
No comments:
Post a Comment